IMMUNEERING CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.64 USD | +5.13% |
|
+11.56% | -77.69% |
Chart calendar Immuneering Corporation
0b10ea417726584444ed8.VKOf9SzPpdaOJOgxjMf2lG2xQnCnbeCgRIqiUOzAvhc.LsL1pG22l5i7drkD4YyzxgHrJwb9B9fBAMKRAaqEkzoNxciGdaz67v8UuQ~ea8e094a8df5039b08ef16fed163f0d0
Upcoming events on Immuneering Corporation
Past events on Immuneering Corporation
| 11/04/2024 20:00 | Needham Healthcare Conference |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract No: 4195 |
| 14/03/2024 12:30 | Business Update Call |
| 05/03/2024 17:50 | TD Cowen Health Care Conference |
| 01/03/2024 13:00 | Q4 2023 Earnings Release |
| 13/02/2024 20:20 | Oppenheimer Healthcare Life Sciences Conference |
| 07/02/2024 18:00 | Guggenheim Healthcare Talks Biotechnology Conference |
| 30/11/2023 16:30 | Piper Sandler Healthcare Conference |
| 09/11/2023 21:05 | Q3 2023 Earnings Release |
| 12/10/2023 17:30 | AACR-NCI-EORTC International Conference - Abstract number: A093 |
| 12/10/2023 17:30 | AACR-NCI-EORTC International Conference - Abstract number : A134 |
| 13/09/2023 15:10 | Morgan Stanley Global Healthcare Conference |
| 03/08/2023 21:05 | Q2 2023 Earnings Release |
| 14/06/2023 16:00 | Annual General Meeting |
| 08/06/2023 15:00 | Jefferies Global Healthcare Conference |
| 04/05/2023 21:05 | Q1 2023 Earnings Release |
| 19/04/2023 17:45 | Needham Healthcare Conference |
| 18/04/2023 14:00 | American Association for Cancer Research Meeting - Abstract No 4265 |
| 14/03/2023 18:40 | Oppenheimer Healthcare Conference |
| 07/03/2023 21:45 | American Association for Cancer Research Special conference - Abstract Number: B021 |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 2,08 2,44 -14.91% | 0,32 0,42 -24.74% | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -33,8 -34,0 0.61% | -51,5 -52,1 1.23% | -58,1 -58,2 0.17% | -72,1 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -33,9 -32,4 -4.55% | -51,7 -53,2 2.77% | -58,4 -57,3 -1.92% | -75,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -33,8 -32,3 -4.7% | -50,5 -52,7 4.2% | -53,5 -52,5 -1.86% | -73,8 |
|
Net income Million USD | Released Forecast Spread | -17,0 | -33,5 -32,3 -3.75% | -50,5 -52,7 4.2% | -53,5 -52,5 -1.86% | -73,0 |
|
EPS USD | Released Forecast Spread | -4,82 | -2,46 -3,52 30.16% | -1,91 -2,00 4.26% | -1,88 -1,83 -2.52% | -1,85 |
| Announcement Date | 13/05/21 | 10/03/22 | 06/03/23 | 01/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,19 0,54 -64.6% | 0,18 0,18 0.93% | 0,09 0,18 -46.75% | 0,04 0,15 -74.8% | 0,00 0,05 -99.08% | 0,00 0,01 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,1 -9,89 -12.42% | -12,9 -11,9 -8.65% | -11,6 -13,9 15.91% | -13,2 -13,2 0.11% | -14,0 -15,7 10.66% | -14,7 -14,8 0.68% | -13,5 -15,5 12.67% | -13,9 -15,0 7.09% | -16,3 -15,0 -8.45% | -17,5 | -18,6 | -20,1 | -21,9 | -23,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,1 -9,78 -13.37% | -12,9 -11,8 -9.4% | -11,5 -13,7 15.67% | -12,8 -13,1 1.84% | -13,2 -15,5 14.37% | -13,6 -14,5 6.03% | -12,2 -15,0 18.58% | -12,6 -14,3 11.79% | -15,1 -14,1 -6.88% | -16,7 | -18,0 | -19,7 | -21,7 | -22,1 |
|
Net income Million USD | Released Forecast Spread | -10,8 -9,78 -10.23% | -12,9 -11,8 -9.4% | -11,5 -13,7 15.67% | -12,8 -13,1 1.84% | -13,2 -15,5 14.37% | -13,6 -14,5 6.03% | -12,2 -15,0 18.58% | -12,6 -14,3 11.79% | -15,1 -14,1 -6.88% | -16,6 | -17,8 | -19,3 | -20,8 | -22,1 |
|
EPS USD | Released Forecast Spread | -0,05 -0,38 86.84% | -0,49 -0,45 -8.89% | -0,44 -0,52 15.38% | -0,49 -0,49 0% | -0,50 -0,58 14.04% | -0,51 -0,55 6.42% | -0,43 -0,51 16.39% | -0,43 -0,49 11.94% | -0,52 -0,46 -12.43% | -0,51 | -0,49 | -0,49 | -0,43 | -0,50 |
| Announcement Date | 10/03/22 | 10/05/22 | 10/08/22 | 10/11/22 | 06/03/23 | 04/05/23 | 03/08/23 | 09/11/23 | 01/03/24 | - | - | - | - | - |
More events
Past sector events for Immuneering Corporation
| 02/05/2024 21:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMRX Stock
- Calendar Immuneering Corporation
